elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26740235-1F8E17F1-6EF0-40F3-9DF0-537BC3EE172C
Q26740235-1F8E17F1-6EF0-40F3-9DF0-537BC3EE172C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26740235-1F8E17F1-6EF0-40F3-9DF0-537BC3EE172C
Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod
P2860
Q26740235-1F8E17F1-6EF0-40F3-9DF0-537BC3EE172C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26740235-1F8E17F1-6EF0-40F3-9DF0-537BC3EE172C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4c8b205977baf6e13f07f6bc54e2eef4cc77381b
P2860
Multisource drug policies in Latin America: survey of 10 countries.